Viewing Study NCT05864794


Ignite Creation Date: 2025-12-25 @ 1:41 AM
Ignite Modification Date: 2025-12-27 @ 8:16 AM
Study NCT ID: NCT05864794
Status: RECRUITING
Last Update Posted: 2024-05-23
First Post: 2023-04-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Value of Screening MRI Brain in Stage IV Non-small Cell Lung Cancer
Sponsor: University Medical Center Groningen
Organization:

Study Overview

Official Title: ValUe of Screening MRI Brain in Patients With Newly Diagnosed Stage IV Non-oncogene Addicted Non-small Cell Lung CANcer - The VULCAN Trial
Status: RECRUITING
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: VULCAN
Brief Summary: Patients with newly diagnosed stage IV non-oncogene addicted NSCLC, who are fit for systemic treatment and don't have any symptoms of brain disease will undergo an MRI of the brain to screen for brain disease.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: